EP3315114B1 - Production method for easy-to-take solid preparation, and easy-to-take solid preparation - Google Patents
Production method for easy-to-take solid preparation, and easy-to-take solid preparation Download PDFInfo
- Publication number
- EP3315114B1 EP3315114B1 EP16817904.2A EP16817904A EP3315114B1 EP 3315114 B1 EP3315114 B1 EP 3315114B1 EP 16817904 A EP16817904 A EP 16817904A EP 3315114 B1 EP3315114 B1 EP 3315114B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- easy
- solid preparation
- pestle
- take solid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 35
- 239000007787 solid Substances 0.000 title claims description 28
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 238000000034 method Methods 0.000 claims description 43
- 239000011248 coating agent Substances 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 18
- 239000003349 gelling agent Substances 0.000 claims description 16
- 239000004570 mortar (masonry) Substances 0.000 claims description 16
- 238000000748 compression moulding Methods 0.000 claims description 13
- 239000000314 lubricant Substances 0.000 claims description 12
- 229920003169 water-soluble polymer Polymers 0.000 claims description 12
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012778 molding material Substances 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 9
- 239000008116 calcium stearate Substances 0.000 claims description 9
- 235000013539 calcium stearate Nutrition 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- -1 sucrose fatty acid ester Chemical class 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 5
- 239000000661 sodium alginate Substances 0.000 claims description 5
- 229940005550 sodium alginate Drugs 0.000 claims description 5
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 229940014259 gelatin Drugs 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 239000000203 mixture Substances 0.000 description 19
- 239000003814 drug Substances 0.000 description 11
- 238000007906 compression Methods 0.000 description 9
- 230000006835 compression Effects 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000306 component Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 7
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- 239000012752 auxiliary agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008199 coating composition Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007908 dry granulation Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003742 agents affecting metabolism Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000003555 analeptic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Definitions
- the present invention relates to a method for the production of an easy-to-take solid preparation, which is mainly characterized in that a coating processing for providing an easy-to-take property is simply performed in a dry process, to the easy-to-take solid preparation and the like.
- the preparations are formulated into liquid or jelly preparation form in many cases.
- a content of a main drug is high, it will be difficult to mask its taste.
- an active ingredient such as a drug is unstable in water, it will be difficult to be formulated in any preparation form.
- These techniques use processes such as, for example, 1) formulating gell into a tablet by freeze-drying of; 2) punching into a circle shape a film of gelling layers comprising a drug layer between them; 3) punching into a circle shape gelling film layers comprising a tablet between them; 4) spraying a coating solution for gelling on a tablet, and the like.
- Patent Literature (PTL) 1 and 3 disclose a coating composition for use in an easy-to-take solid preparation, which comprises a first thickener of a metal-crosslinking thickener, a polyvalent metal compound, and a second thickener; a method for the production of a preparation for oral administration by spray-coating alcohol solution having the coating composition dispersed therein onto a drug core comprising an active ingredient; and the preparation for oral administration produced thereby.
- Patent Literature (PTL) 2 discloses a powder compression-molding machine to perform simultaneously compression molding of an inner core (core tablet); and a manufacturing method of a product, comprising applying a lubricant to a mortar inner surface, the bottom end surface of an upper-pestle, and the top end surface of a lower-pestle with a first injection device, applying a coating agent over the resulting lubricant layer with a second injection device, filling the mortar with powder, and subsequently compressing the powder with the upper- and lower-pestles.
- Patent Literatures discloses or suggests a dry method for the production of an easy-to-take solid preparation that is coated with a gelling agent.
- an object of the present invention is to solve such technical problems in the arts, and to provide a method for the production of an easy-to-take solid preparation, which is mainly characterized in that a coating processing for providing the easy-to-take property is simply performed by using a gelling agent in a dry process, without going through a wet condition, the easy-to-take solid preparation and the like.
- the term "easy-to-take” generally means “easy to drink” or “easy to swallow”, as the characteristics or property of the solid preparations and the like.
- the present invention provides the following aspects.
- the easy-to-take solid preparation that is easy to swallow (or, that has an excellent easiness to swallow) can be easily produced by means of a continuous tableting machine conventionally used such as, for example, a simple machine having one injection device, without using any specialized device, means or operation.
- the present invention makes it possible to realize the "easy-to-take” property with the coating processing only by means of mixing and dry compression-molding of the powder so as to produce the easy-to-take solid preparation without going through any wet condition, the functional or active ingredient can be used even if their stability for the solvent is low.
- the present invention relates to a dry-process method for the production of an easy-to-take solid preparation wherein a compression-molded core is coated with a coating agent comprising a gelling agent that will show slipperiness when it is brought into contact with water, comprising directly applying only powder of the coating agent to a mortar inner surface, the bottom end surface of an upper-pestle, and the top end surface of a lower-pestle, and subsequently loading and integrally compression-molding a core-molding material.
- the mortar, the upper-pestle, and the lower-pestle are a member for compressing the coating agent and the core-molding material along the four directions, so as to mold the easy-to-take solid preparation wherein the compression-molded core is coated with the coating agent.
- They comprise any other members that are named differently in any other powder compression-molding machines or devices as long as they have substantially the same functions and/or properties as the above ones.
- the method according to the present invention does not need such a complicated powder compression-molding machine or device as disclosed in PTL 2, and it can be therefore carried out using such a simple tableting machine as disclosed in the present specification or the continuous tableting machine conventionally used such as, for example, the simple machine having only one injection device.
- Each process of applying the powder of the coating agent to the mortar inner surface, the bottom end surface of the upper-pestle, and the top end surface of the lower-pestle; loading or loading the core-molding material, etc. may be performed by any means or method known for those skilled in the art depending on the production machine used and the like.
- the application of the powder of the coating agent may be carried out by painting or spraying the powder of the coating agent to the mortar inner surface, the bottom end surface of the upper-pestle, and the top end surface of the lower-pestle by using any appropriate means.
- the gelling agent that will show slipperiness when it is brought into contact with water means a material that will form a slippery surface of a solid tablet under the moisture condition in the oral cavity when it is taken without water so as to promote the slipperiness of the tablet itself. Such promotion of the slipperiness of the tablet will also make the tablet easy to swallow even when it is taken with water.
- the representative examples of the gelling agent include the water-soluble polymer that is selected from the group consisting of sodium carboxylmethylcellulose, sodium alginate, carrageenan, xanthan gum and gelatin.
- the water-soluble polymer may be naturally-occurring or synthetic one.
- the coating agent may comprise the gelling agent only, or further comprise other ingredients as long as they will not inhibit the function of the gelling agent.
- any material known as a lubricant in the art for example, those selected from the group consisting of calcium stearate, magnesium stearate and sucrose fatty acid ester may be comprised in the coating agent so as to obtain the advantage that tableting trouble will not likely occur.
- the ingredients other than the gelling agent may be usually comprised at from 0.01 to 10 % by weight of the whole coating agent.
- the "powder” in the present invention means the aggregate of solid particulates, which may include powder having finer size or shape than granules or grains.
- the whole or a part of the surface of the solid preparation may be in the coated condition according to the present invention.
- the ingredients comprised in the powder of the coating agent and the core-molding material may be used as they are, or the powder of the coating agent and the core-molding material may be prepared by any means or method known in the art such as a dry granulation process, a wet granulation process and the like.
- the dry granulation process includes crushing granulation and roll-compressing method, comprising the steps of compressing each powder components into small bulks with a pressure, and appropriately crushing and granulating them, for example.
- the wet granulation process is a method in which each component is dispersed in the presence of water, and the dispersion is dried to form complexes.
- spray methods such as spray drying, tumbling granulation, agitation granulation and fluidized-bed granulation; freeze-drying method; kneading granulation, and the like can be mentioned. They can be produced by any of these methods known to a person skilled in the art.
- the easy-to-take solid preparation produced by the method according to the present invention is an oral formulation, and has uses, for example, as various foods such as supplemental foods, nutrition function foods and health foods; and as pharmaceuticals.
- the core-molding material in the present invention may therefore optionally comprise various components known for those skilled in the art depending on the above uses.
- the foods may comprise various nutritional components such as proteins, carbohydrates, lipids and minerals; components for health foods such as various extracts from microorganisms, plants and animals; various vitamins and their derivatives; and designated or existing additives according to Food Sanitation Law, Art. 10; and other components acceptable as a food component (a food additive) listed in a list of general additives for food and drink, such as acidulants, sweeteners, excipients, surfactants, lubricants, auxiliary agents, corrigents, flavoring agents, colorants, and stabilizing agents.
- the pharmaceuticals may comprise in addition to a medicinal or active ingredient, other any pharmaceutically acceptable components, such as excipients, surfactants, lubricants, auxiliary agents, acidulants, sweeteners, corrigents, flavoring agents, colorants, and stabilizing agents, when needed.
- these optional components for example, appropriate ingredients described in "Japanese Pharmaceutical Excipients Directory” (YAKUJI NIPPO LIMITED) or the Japanese Pharmacopoeia; designated or existing additives according to Food Sanitation Law, Art. 10; natural flavor; and additives listed in a list of general additives for food and drink can be used.
- the kind of the medicinal ingredient and the above auxiliaries There is no limitation in the kind of the medicinal ingredient and the above auxiliaries.
- the blending ratios of each optional ingredient (component) are not particularly limited as long as the desired effects of the present invention are brought about, and the blending ratios can properly be determined by those skilled in the art.
- the medicinal ingredients may include, for example, agents affecting each organ such as the central nervous system, peripheral nervous system, a sensory organ, a circulatory organ, a respiratory organ and a digestive organ and an urogenital organ; hormone drug; agents affecting metabolism such as a vitamin drug, an analeptic, an agent affecting blood and body fluid; agents affecting the function of tissue and cell such as an agent activating cellular function, an agent affecting tumors, an radioactive medicine, an anti-allergic agent; medicines based on a medical prescription relating to herbal medicines and Chinese medicines; antibiotics; agents for chemotherapy, biological drug; agents for pathogenic organisms such as parasites; agents for formulation use, diagnosis, public health and in-vitro diagnosis.
- agents affecting each organ such as the central nervous system, peripheral nervous system, a sensory organ, a circulatory organ, a respiratory organ and a digestive organ and an urogenital organ
- hormone drug agents affecting metabolism such as a vitamin drug, an analeptic, an agent affecting blood and body fluid
- the lubricants that may be comprised in the core-molding material can reduce the tableting damage due to the compression molding.
- Those skilled in the art may optionally select the various conditions in the processes of the production method according to the present invention, such as pressure and time of the compression-molding, and amounts of the coating agent and the core-molding material, depending on the scale and kind of the machine to be used in the method, the size and application of a desired easy-to-take solid preparation and the like.
- tablet compression force in the compression-molding usually ranges from 2 to 100 kN.
- the size, shape and the like of the easy-to-take solid preparation according to the present invention is usually within a range of from 3 to 20 mm in diameter and of from 15 to 2000 mg in weight, and it may have any shape known for those skilled in the art such as those of a flat with bevel-edge tablet and a truly-flat tablet.
- the thickness of an outer layer (coating) consisting of the coating agent ranges from about 0.01 to about 0.1 mm. These values can be determined by any method known for those skilled in the art.
- the present invention further relates to the easy-to-take solid preparation that is produced by any one of the above methods .
- the powder composition for coating the solid preparation comprising the gelling agent that will show slipperiness when it is brought into contact with water, especially, the water-soluble polymer.
- a preferable example of the composition is one that comprises sodium carboxylmethylcellulose as the water-soluble polymer.
- Hardness was measured with a digital Kiya hardness tester (Fujiwara Scientific Company Co., Ltd.). The measurement for the hardness was repeated six times for each tablet, and an average value thereof was regarded as a measurement result.
- slipperiness Three men and women, respectively (six in total) took the tablet without water, and slipperiness was evaluated in accordance with three-stage criteria below:
- the resulting mixture was then subjected to tableting at a tablet compression force of 10 kN with a simple tableting machine (HANDTAB-100, ICHIHASHI-SEIKI Co., Ltd.) to thereby obtain a flat with bevel-edge tablet having a diameter of 8.0 mm and a weight of 250 mg, wherein sodium carboxylmethylcellulose (CMC Daicel, Daicel FineChem Ltd.) had been applied as a coating agent in advance to a mortar inner surface, and the surfaces of an upper-pestle and a lower-pestle in the above tableting machine.
- CMC Daicel Daicel FineChem Ltd.
- Example 2 The resulting mixture was then subjected to tableting in the same way as in Example 1, except that sodium alginate (KIMICA ALGIN, KIMICA Corporation) had been applied as the coating agent in advance to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine and that a tablet compression force was 8 kN, to thereby obtain an R6.5 tablet having a diameter of 8.0 mm and a weight of 200 mg.
- sodium alginate KIMICA ALGIN, KIMICA Corporation
- Example 2 The resulting mixture was then subjected to tableting in the same way as in Example 1, except that xanthan gum (Xanthan gum XG800, Mitsubishi-Chemical Foods Corporation) had been applied as the coating agent in advance to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine and that a tablet compression force was 8 kN, to thereby obtain an R6.5 tablet having a diameter of 8.0 mm and a weight of 200 mg.
- xanthan gum Xanthan gum XG800, Mitsubishi-Chemical Foods Corporation
- Table 1 demonstrate that the tablets produced in Examples 1 to 5 were more slippery and easy-to-swallow, wherein they were tableted after the water-soluble polymer such as sodium carboxylmethylcellulose, sodium alginate or xanthan gum had been applied to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine, than those obtained in Comparative Examples 1 and 2 wherein the water-soluble polymer had not been applied. Furthermore, it was not necessary in Examples 1-5 to apply in advance the lubricant to the mortar inner surface, the bottom end surface of the upper-pestle, and the top end surface of the lower-pestle as in the method disclosed PTL 2.
- the water-soluble polymer such as sodium carboxylmethylcellulose, sodium alginate or xanthan gum
- the present invention significantly contributes to research and development of the method for the production of the easy-to-take solid preparation, the easy-to-take solid preparation and the like.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
- The present invention relates to a method for the production of an easy-to-take solid preparation, which is mainly characterized in that a coating processing for providing an easy-to-take property is simply performed in a dry process, to the easy-to-take solid preparation and the like.
- Taking properties of a preparation for oral administration have been previously improved for patients who have difficulty in swallowing, and elderly people and children who have a weak swallowing ability and the like.
- For example, the preparations are formulated into liquid or jelly preparation form in many cases. However, when a content of a main drug is high, it will be difficult to mask its taste. And, when an active ingredient such as a drug is unstable in water, it will be difficult to be formulated in any preparation form.
- Accordingly, easy-to-take preparations have been recently developed for facilitating swallowing of the solid preparation, wherein the surface of the preparations is coated with a gelling agent so that they will show slipperiness and become slippery against mucous membrane and easy to swallow when they are brought into contact with water in oral cavity.
- These techniques use processes such as, for example, 1) formulating gell into a tablet by freeze-drying of; 2) punching into a circle shape a film of gelling layers comprising a drug layer between them; 3) punching into a circle shape gelling film layers comprising a tablet between them; 4) spraying a coating solution for gelling on a tablet, and the like.
- Patent Literature (PTL) 1 and 3 disclose a coating composition for use in an easy-to-take solid preparation, which comprises a first thickener of a metal-crosslinking thickener, a polyvalent metal compound, and a second thickener; a method for the production of a preparation for oral administration by spray-coating alcohol solution having the coating composition dispersed therein onto a drug core comprising an active ingredient; and the preparation for oral administration produced thereby.
- Patent Literature (PTL) 2 discloses a powder compression-molding machine to perform simultaneously compression molding of an inner core (core tablet); and a manufacturing method of a product, comprising applying a lubricant to a mortar inner surface, the bottom end surface of an upper-pestle, and the top end surface of a lower-pestle with a first injection device, applying a coating agent over the resulting lubricant layer with a second injection device, filling the mortar with powder, and subsequently compressing the powder with the upper- and lower-pestles.
- However, neither of these Patent Literatures discloses or suggests a dry method for the production of an easy-to-take solid preparation that is coated with a gelling agent.
-
- PTL 1: International Publication Pamphlet
WO2011/125798 - PTL 2:
JP-A-2012-35289 - PTL 3:
EP 2762167 A - The conventional treatment with a gelling agent as seen in the prior arts such as PTL 1 and 3 was complicated as it requires the preparation of a gelling agent solution, the transfer to a coating machine after the compression molding and the like. Furthermore, a functional or active ingredient cannot be used if their stability for a solvent in these processes is low.
- The mechanism and operation of the plural injection devices of the powder compression-molding machine of PTL 2 is complicated as well.
- Accordingly, an object of the present invention is to solve such technical problems in the arts, and to provide a method for the production of an easy-to-take solid preparation, which is mainly characterized in that a coating processing for providing the easy-to-take property is simply performed by using a gelling agent in a dry process, without going through a wet condition, the easy-to-take solid preparation and the like. The term "easy-to-take" generally means "easy to drink" or "easy to swallow", as the characteristics or property of the solid preparations and the like.
- No patent literature discloses or suggests such technical problems.
- The present inventors have earnestly studied to solve the above problems and completed the invention comprising the following aspects
- Thus, the present invention provides the following aspects.
-
- [Aspect 1]
A dry-process method for the production of an easy-to-take solid preparation wherein a compression-molded core is coated with a coating agent comprising a gelling agent that will show slipperiness when it is brought into contact with water, comprising directly applying only powder of the coating agent to a mortar inner surface, the bottom end surface of an upper-pestle, and the top end surface of a lower-pestle, and subsequently loading and integrally compression-molding a core-molding material. - [Aspect 2]
The method according to Aspect 1, wherein the gelling agent comprises at least one kind of a water-soluble polymer. - [Aspect 3]
The method according to Aspect 2, wherein the water-soluble polymer is selected from the group consisting of sodium carboxylmethylcellulose, sodium alginate, carrageenan, xanthan gum and gelatin. - [Aspect 4]
The method according to Aspect 3 wherein the water-soluble polymer is sodium carboxylmethylcellulose. - [Aspect 5]
The method according to any one of Aspects 1-4, wherein the coating agent further comprises a lubricant. - [Aspect 6]
The method according to Aspect 5, wherein the lubricant is selected from the group consisting of calcium stearate, magnesium stearate and sucrose fatty acid ester. - [Aspect 7]
An easy-to-take solid preparation that is produced by the method according to Claims 1 to 6. - According to the present invention, the easy-to-take solid preparation that is easy to swallow (or, that has an excellent easiness to swallow) can be easily produced by means of a continuous tableting machine conventionally used such as, for example, a simple machine having one injection device, without using any specialized device, means or operation.
- Furthermore, since the present invention makes it possible to realize the "easy-to-take" property with the coating processing only by means of mixing and dry compression-molding of the powder so as to produce the easy-to-take solid preparation without going through any wet condition, the functional or active ingredient can be used even if their stability for the solvent is low.
- The present invention relates to a dry-process method for the production of an easy-to-take solid preparation wherein a compression-molded core is coated with a coating agent comprising a gelling agent that will show slipperiness when it is brought into contact with water, comprising directly applying only powder of the coating agent to a mortar inner surface, the bottom end surface of an upper-pestle, and the top end surface of a lower-pestle, and subsequently loading and integrally compression-molding a core-molding material.
- Thus, it is not necessary to apply in advance the lubricant to the mortar inner surface, the bottom end surface of the upper-pestle, and the top end surface of the lower-pestle as in the method disclosed PTL 2.
- In the method according to the present invention, the mortar, the upper-pestle, and the lower-pestle are a member for compressing the coating agent and the core-molding material along the four directions, so as to mold the easy-to-take solid preparation wherein the compression-molded core is coated with the coating agent. They comprise any other members that are named differently in any other powder compression-molding machines or devices as long as they have substantially the same functions and/or properties as the above ones.
- The method according to the present invention does not need such a complicated powder compression-molding machine or device as disclosed in PTL 2, and it can be therefore carried out using such a simple tableting machine as disclosed in the present specification or the continuous tableting machine conventionally used such as, for example, the simple machine having only one injection device.
- Each process of applying the powder of the coating agent to the mortar inner surface, the bottom end surface of the upper-pestle, and the top end surface of the lower-pestle; loading or loading the core-molding material, etc. may be performed by any means or method known for those skilled in the art depending on the production machine used and the like. For example, the application of the powder of the coating agent may be carried out by painting or spraying the powder of the coating agent to the mortar inner surface, the bottom end surface of the upper-pestle, and the top end surface of the lower-pestle by using any appropriate means.
- The gelling agent that will show slipperiness when it is brought into contact with water according to the present invention means a material that will form a slippery surface of a solid tablet under the moisture condition in the oral cavity when it is taken without water so as to promote the slipperiness of the tablet itself. Such promotion of the slipperiness of the tablet will also make the tablet easy to swallow even when it is taken with water.
- The representative examples of the gelling agent include the water-soluble polymer that is selected from the group consisting of sodium carboxylmethylcellulose, sodium alginate, carrageenan, xanthan gum and gelatin. The water-soluble polymer may be naturally-occurring or synthetic one.
- The coating agent may comprise the gelling agent only, or further comprise other ingredients as long as they will not inhibit the function of the gelling agent. For example, any material known as a lubricant in the art, for example, those selected from the group consisting of calcium stearate, magnesium stearate and sucrose fatty acid ester may be comprised in the coating agent so as to obtain the advantage that tableting trouble will not likely occur. The ingredients other than the gelling agent may be usually comprised at from 0.01 to 10 % by weight of the whole coating agent.
- The "powder" in the present invention means the aggregate of solid particulates, which may include powder having finer size or shape than granules or grains. The whole or a part of the surface of the solid preparation may be in the coated condition according to the present invention.
- The ingredients comprised in the powder of the coating agent and the core-molding material may be used as they are, or the powder of the coating agent and the core-molding material may be prepared by any means or method known in the art such as a dry granulation process, a wet granulation process and the like.
- The dry granulation process includes crushing granulation and roll-compressing method, comprising the steps of compressing each powder components into small bulks with a pressure, and appropriately crushing and granulating them, for example.
- On the other hand, the wet granulation process is a method in which each component is dispersed in the presence of water, and the dispersion is dried to form complexes. As specific examples of the wet granulation process, spray methods such as spray drying, tumbling granulation, agitation granulation and fluidized-bed granulation; freeze-drying method; kneading granulation, and the like can be mentioned. They can be produced by any of these methods known to a person skilled in the art.
- The easy-to-take solid preparation produced by the method according to the present invention is an oral formulation, and has uses, for example, as various foods such as supplemental foods, nutrition function foods and health foods; and as pharmaceuticals.
- The core-molding material in the present invention may therefore optionally comprise various components known for those skilled in the art depending on the above uses.
- For use as the foods, for example, it may comprise various nutritional components such as proteins, carbohydrates, lipids and minerals; components for health foods such as various extracts from microorganisms, plants and animals; various vitamins and their derivatives; and designated or existing additives according to Food Sanitation Law, Art. 10; and other components acceptable as a food component (a food additive) listed in a list of general additives for food and drink, such as acidulants, sweeteners, excipients, surfactants, lubricants, auxiliary agents, corrigents, flavoring agents, colorants, and stabilizing agents.
- For use as the pharmaceuticals, for example, it may comprise in addition to a medicinal or active ingredient, other any pharmaceutically acceptable components, such as excipients, surfactants, lubricants, auxiliary agents, acidulants, sweeteners, corrigents, flavoring agents, colorants, and stabilizing agents, when needed. As these optional components, for example, appropriate ingredients described in "Japanese Pharmaceutical Excipients Directory" (YAKUJI NIPPO LIMITED) or the Japanese Pharmacopoeia; designated or existing additives according to Food Sanitation Law, Art. 10; natural flavor; and additives listed in a list of general additives for food and drink can be used. There is no limitation in the kind of the medicinal ingredient and the above auxiliaries. Also, the blending ratios of each optional ingredient (component) are not particularly limited as long as the desired effects of the present invention are brought about, and the blending ratios can properly be determined by those skilled in the art.
- There is no limitation on an application or kind of the medicinal ingredients, which may include, for example, agents affecting each organ such as the central nervous system, peripheral nervous system, a sensory organ, a circulatory organ, a respiratory organ and a digestive organ and an urogenital organ; hormone drug; agents affecting metabolism such as a vitamin drug, an analeptic, an agent affecting blood and body fluid; agents affecting the function of tissue and cell such as an agent activating cellular function, an agent affecting tumors, an radioactive medicine, an anti-allergic agent; medicines based on a medical prescription relating to herbal medicines and Chinese medicines; antibiotics; agents for chemotherapy, biological drug; agents for pathogenic organisms such as parasites; agents for formulation use, diagnosis, public health and in-vitro diagnosis.
- The lubricants that may be comprised in the core-molding material can reduce the tableting damage due to the compression molding.
- Those skilled in the art may optionally select the various conditions in the processes of the production method according to the present invention, such as pressure and time of the compression-molding, and amounts of the coating agent and the core-molding material, depending on the scale and kind of the machine to be used in the method, the size and application of a desired easy-to-take solid preparation and the like. For example, tablet compression force in the compression-molding usually ranges from 2 to 100 kN.
- There is no limitation on the size, shape and the like of the easy-to-take solid preparation according to the present invention. It is usually within a range of from 3 to 20 mm in diameter and of from 15 to 2000 mg in weight, and it may have any shape known for those skilled in the art such as those of a flat with bevel-edge tablet and a truly-flat tablet. The thickness of an outer layer (coating) consisting of the coating agent ranges from about 0.01 to about 0.1 mm. These values can be determined by any method known for those skilled in the art.
- The present invention further relates to the easy-to-take solid preparation that is produced by any one of the above methods . Also disclosed is the powder composition for coating the solid preparation, comprising the gelling agent that will show slipperiness when it is brought into contact with water, especially, the water-soluble polymer. A preferable example of the composition is one that comprises sodium carboxylmethylcellulose as the water-soluble polymer.
- Hereinafter, the present invention will more specifically be described with reference to Examples. However, the present invention is not considered to be limited to the Examples.
- Values of the hardness and slipperiness of the tablets obtained in the Examples and Comparative Example were measured based on the following conditions/methods.
- Hardness: Hardness (N) was measured with a digital Kiya hardness tester (Fujiwara Scientific Company Co., Ltd.). The measurement for the hardness was repeated six times for each tablet, and an average value thereof was regarded as a measurement result.
- Slipperiness: Three men and women, respectively (six in total) took the tablet without water, and slipperiness was evaluated in accordance with three-stage criteria below:
- 3:
- slippery and easy to swallow
- 2:
- slightly slippery but hard to swallow
- 1:
- hardly slippery and hard to swallow
- 18 g of lactose (FlowLac90, MEGGLE JAPAN Co., LTD) and 2 g of hydroxypropylcellulose (HPC-SSL-SFP, NIPPON SODA CO., LTD.) were mixed to give a mixture. The resulting mixture was then subjected to tableting at a tablet compression force of 10 kN with a simple tableting machine (HANDTAB-100, ICHIHASHI-SEIKI Co., Ltd.) to thereby obtain a flat with bevel-edge tablet having a diameter of 8.0 mm and a weight of 250 mg, wherein sodium carboxylmethylcellulose (CMC Daicel, Daicel FineChem Ltd.) had been applied as a coating agent in advance to a mortar inner surface, and the surfaces of an upper-pestle and a lower-pestle in the above tableting machine.
- 17.9 g of lactose (FlowLac90, MEGGLE JAPAN Co., LTD), 2 g of hydroxypropylcellulose (HPC-SSL-SFP, NIPPON SODA CO., LTD.) and 0.1 g of calcium stearate (Taihei Chemical Industrial Co. Ltd.) were mixed to give a mixture. The resulting mixture was then subjected to tableting in the same way as in Example 1, except for at a tablet compression force of 12 kN to thereby obtain a flat with bevel-edge tablet having a diameter of 8.0 mm and a weight of 250 mg.
- 18 g of lactose (FlowLac90, MEGGLE JAPAN Co., LTD) and 2 g of hydroxypropylcellulose (HPC-SSL-SFP, NIPPON SODA CO., LTD.) were mixed to give a mixture. The resulting mixture was then subjected to tableting in the same way as in Example 1, except that a mixture of 4.975 g of sodium carboxylmethylcellulose (CMC Daicel, Daicel FineChem Ltd.) and 0.025 g of calcium stearate (Taihei Chemical Industrial Co. Ltd.) had been applied as the coating agent in advance to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine, to thereby obtain a flat with bevel-edge tablet having a diameter of 8.0 mm and a weight of 250 mg.
- 18 g of lactose (FlowLac90, MEGGLE JAPAN Co., LTD) and 2 g of hydroxypropylcellulose (HPC-SSL-SFP, NIPPON SODA CO., LTD.) were mixed to give a mixture. The resulting mixture was then subjected to tableting in the same way as in Example 1, except that a little amount of calcium stearate (Taihei Chemical Industrial Co. Ltd.) had been applied in advance to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine and that a tablet compression force was 8 kN, to thereby obtain a flat with bevel-edge tablet having a diameter of 8.0 mm and a weight of 250 mg.
- 18 g of lactose (FlowLac90, MEGGLE JAPAN Co., LTD), 1.8 g of hydroxypropylcellulose (HPC-SSL-SFP, NIPPON SODA CO., LTD.) and 0.2 g of calcium stearate (Taihei Chemical Industrial Co. Ltd.) were mixed to give a mixture. The resulting mixture was then subjected to tableting in the same way as in Example 1, except that sodium alginate (KIMICA ALGIN, KIMICA Corporation) had been applied as the coating agent in advance to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine and that a tablet compression force was 8 kN, to thereby obtain an R6.5 tablet having a diameter of 8.0 mm and a weight of 200 mg.
- 18 g of lactose (FlowLac90, MEGGLE JAPAN Co., LTD), 1.8 g of hydroxypropylcellulose (HPC-SSL-SFP, NIPPON SODA CO., LTD.) and 0.2 g of calcium stearate (Taihei Chemical Industrial Co. Ltd.) were mixed to give a mixture. The resulting mixture was then subjected to tableting in the same way as in Example 1, except that xanthan gum (Xanthan gum XG800, Mitsubishi-Chemical Foods Corporation) had been applied as the coating agent in advance to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine and that a tablet compression force was 8 kN, to thereby obtain an R6.5 tablet having a diameter of 8.0 mm and a weight of 200 mg.
- 17.9 g of lactose (FlowLac90, MEGGLE JAPAN Co., LTD), 2 g of hydroxypropylcellulose (HPC-SSL-SFP, NIPPON SODA CO., LTD.) and 0.1 g of calcium stearate (Taihei Chemical Industrial Co. Ltd.) were mixed to give a mixture. The resulting mixture was then subjected to tableting in the same way as in Example 1, except for at a tablet compression force of 6 kN to thereby obtain an R6.5 tablet having a diameter of 8.0 mm and a weight of 200 mg.
- Tablet Compression Force, Tablet Hardness and Slipperiness of each tablet produced in the above Examples are shown in Table 1.
[Table 1] Ex.1 Ex.2 Ex.3 Comp. Ex.1 Ex.4 Ex.5 Comp. Ex.2 Tablet Compression Force (kN) 10 12 10 8 8 8 6 Tablet Hardness (N) 100 99 102 82 73 72 109 Slipperiness 3 3 3 1 3 3 1 - The results shown in Table 1 demonstrate that the tablets produced in Examples 1 to 5 were more slippery and easy-to-swallow, wherein they were tableted after the water-soluble polymer such as sodium carboxylmethylcellulose, sodium alginate or xanthan gum had been applied to the mortar inner surface, and the surfaces of the upper-pestle and the lower-pestle in the above tableting machine, than those obtained in Comparative Examples 1 and 2 wherein the water-soluble polymer had not been applied. Furthermore, it was not necessary in Examples 1-5 to apply in advance the lubricant to the mortar inner surface, the bottom end surface of the upper-pestle, and the top end surface of the lower-pestle as in the method disclosed PTL 2.
- The present invention significantly contributes to research and development of the method for the production of the easy-to-take solid preparation, the easy-to-take solid preparation and the like.
Claims (7)
- A dry-process method for the production of an easy-to-take solid preparation wherein a compression-molded core is coated with a coating agent comprising a gelling agent that will show slipperiness when it is brought into contact with water, comprising directly applying only powder of the coating agent to a mortar inner surface, the bottom end surface of an upper-pestle, and the top end surface of a lower-pestle, and subsequently loading and integrally compression-molding a core-molding material.
- The method according to Claim 1, wherein the gelling agent comprises at least one kind of a water-soluble polymer.
- The method according to Claim 2, wherein the water-soluble polymer is selected from the group consisting of sodium carboxylmethylcellulose, sodium alginate, carrageenan, xanthan gum and gelatin.
- The method according to Claim 3 wherein the water-soluble polymer is sodium carboxylmethylcellulose.
- The method according to any one of Claims 1-4, wherein the coating agent further comprises a lubricant.
- The method according to Claim 5, wherein the lubricant is selected from the group consisting of calcium stearate, magnesium stearate and sucrose fatty acid ester.
- An easy-to-take solid preparation that is produced by the method according to Claims 1 to 6.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015129529 | 2015-06-29 | ||
PCT/JP2016/069112 WO2017002796A1 (en) | 2015-06-29 | 2016-06-28 | Production method for easy-to-take solid preparation, and easy-to-take solid preparation |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3315114A1 EP3315114A1 (en) | 2018-05-02 |
EP3315114A4 EP3315114A4 (en) | 2019-02-27 |
EP3315114B1 true EP3315114B1 (en) | 2020-08-12 |
Family
ID=57608096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16817904.2A Active EP3315114B1 (en) | 2015-06-29 | 2016-06-28 | Production method for easy-to-take solid preparation, and easy-to-take solid preparation |
Country Status (7)
Country | Link |
---|---|
US (1) | US10959915B2 (en) |
EP (1) | EP3315114B1 (en) |
JP (1) | JP6749903B2 (en) |
KR (1) | KR20180021377A (en) |
CN (1) | CN107708648B (en) |
TW (1) | TWI716415B (en) |
WO (1) | WO2017002796A1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09104621A (en) * | 1995-10-06 | 1997-04-22 | Bentoretsupu Sante Kk | Medicine coated with gelatinizing agent, lubricating agent and lubricant |
CN100342846C (en) * | 1999-10-13 | 2007-10-17 | 协和发酵工业株式会社 | Compression molded product and production method therefor |
JP4817573B2 (en) | 1999-10-13 | 2011-11-16 | 協和発酵バイオ株式会社 | Compression molded product and method for producing the same |
WO2009098520A2 (en) * | 2008-02-06 | 2009-08-13 | University Of East Anglia | Composition and method for assisting swallowing |
US9603805B2 (en) * | 2011-09-30 | 2017-03-28 | Mochida Pharmaceutical Co., Ltd. | Easily dosable solid preparation |
AU2012318239B2 (en) * | 2011-11-01 | 2015-07-09 | Celgene Corporation | Methods for treating cancers using oral formulations of cytidine analogs |
JP6042610B2 (en) * | 2011-12-27 | 2016-12-14 | 三栄源エフ・エフ・アイ株式会社 | Gelling agent for protein-containing food and drink |
-
2016
- 2016-06-27 TW TW105120166A patent/TWI716415B/en not_active IP Right Cessation
- 2016-06-28 EP EP16817904.2A patent/EP3315114B1/en active Active
- 2016-06-28 US US15/737,939 patent/US10959915B2/en active Active
- 2016-06-28 JP JP2017526363A patent/JP6749903B2/en not_active Expired - Fee Related
- 2016-06-28 WO PCT/JP2016/069112 patent/WO2017002796A1/en active Application Filing
- 2016-06-28 CN CN201680038599.5A patent/CN107708648B/en not_active Expired - Fee Related
- 2016-06-28 KR KR1020187000292A patent/KR20180021377A/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
KR20180021377A (en) | 2018-03-02 |
US20180168934A1 (en) | 2018-06-21 |
JPWO2017002796A1 (en) | 2018-05-24 |
CN107708648B (en) | 2021-01-01 |
TWI716415B (en) | 2021-01-21 |
US10959915B2 (en) | 2021-03-30 |
EP3315114A4 (en) | 2019-02-27 |
TW201709901A (en) | 2017-03-16 |
JP6749903B2 (en) | 2020-09-02 |
CN107708648A (en) | 2018-02-16 |
WO2017002796A1 (en) | 2017-01-05 |
EP3315114A1 (en) | 2018-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11058643B2 (en) | Composition for outer layer of solid preparation, and easy-to-take solid preparation including said composition for outer layer | |
US11273129B2 (en) | Particle composition for easy-to-use solid preparation and easy-to-use solid preparation including said particle composition | |
AU2015251692A1 (en) | Disintegrating particle composition including microfibrous cellulose | |
US10959916B2 (en) | Production method for easy-to-take solid preparation (nucleated tablet), and easy-to-take solid preparation | |
JP3884056B1 (en) | Method for producing intraoral rapidly disintegrating tablet | |
JP6469234B2 (en) | Super-fast disintegrating tablet and method for producing the same | |
EP3315114B1 (en) | Production method for easy-to-take solid preparation, and easy-to-take solid preparation | |
EP3238712A1 (en) | Very rapidly disintegrating tablet, and method for producing same | |
TW201729798A (en) | Intraoral retentive disintegrating solid preparation, method for producing same and powder composition used in said production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180109 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190124 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/28 20060101AFI20190118BHEP Ipc: A61J 3/06 20060101ALI20190118BHEP Ipc: A61K 47/38 20060101ALI20190118BHEP Ipc: A61K 47/36 20060101ALI20190118BHEP Ipc: B30B 11/34 20060101ALI20190118BHEP Ipc: A61J 3/10 20060101ALI20190118BHEP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602016041969 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61J0003100000 Ipc: A61K0009280000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61J 3/06 20060101ALI20200330BHEP Ipc: A61K 47/36 20060101ALI20200330BHEP Ipc: A61K 9/28 20060101AFI20200330BHEP Ipc: A61J 3/10 20060101ALI20200330BHEP Ipc: A61K 47/38 20060101ALI20200330BHEP Ipc: B30B 11/34 20060101ALI20200330BHEP |
|
INTG | Intention to grant announced |
Effective date: 20200416 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016041969 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1300826 Country of ref document: AT Kind code of ref document: T Effective date: 20200915 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200812 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201112 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201113 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201112 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1300826 Country of ref document: AT Kind code of ref document: T Effective date: 20200812 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016041969 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |
|
26N | No opposition filed |
Effective date: 20210514 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210628 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210630 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210628 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210630 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220627 Year of fee payment: 7 Ref country code: DE Payment date: 20220620 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20220628 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201214 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20160628 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602016041969 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230628 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240103 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230628 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200812 |